Company / Shares Outstanding
SELLAS Life Sciences Group, Inc. Shares Outstanding History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
61.2M
FY2024
5-year range
5.1M / 61.2M
FY2020-FY2024
Trend
+191.4%
vs FY2023
Sector context
#142 of 212
Health Care
What the data says
At 61202412.00, SELLAS Life Sciences Group, Inc.'s shares outstanding ranks #71 of 212 in the Health Care sector. Shares Outstanding has increased for 6 consecutive years, from 261542.00 in FY2018 to 61202412.00 in FY2024.
Based on SEC 10-K filings.
61202412.00 in FY2024 with a 5-year CAGR of +88.7%.
Increased from 15895637.00 to 61202412.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +62.5%
- 5-Year CAGR
- +88.7%
- 10-Year CAGR
- -
Sector benchmark
#71 of 212 in Health CareTop 33% of 212This company 61.2M Sector average 306.7M
▼
-80.0% below sector average
Key checks
Key Insights
- SELLAS Life Sciences Group, Inc.'s shares outstanding has grown for 6 consecutive years.
- In FY2024, shares outstanding increased 191.4% year-over-year.
- Ranks #142 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 61.2M | +191.4% |
| FY2023 | 21.0M | +32.1% |
| FY2022 | 15.9M | +11.5% |
| FY2021 | 14.3M | +180.6% |
| FY2020 | 5.1M | +98.5% |
| FY2019 | 2.6M | +878.3% |
| FY2018 | 261.5K | -88.8% |
| FY2017 | 2.3M | -71.1% |
| FY2016 | 8.1M | -92.6% |
| FY2015 | 109.4M | +0.0% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026